Literature DB >> 12228284

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant.

Priscille Brodin1, Karin Eiglmeier, Magali Marmiesse, Alain Billault, Thierry Garnier, Stefan Niemann, Stewart T Cole, Roland Brosch.   

Abstract

Mycobacterium microti is a member of the Mycobacterium tuberculosis complex that causes tuberculosis in voles. Most strains of M. microti are harmless for humans, and some have been successfully used as live tuberculosis vaccines. In an attempt to identify putative virulence factors of the tubercle bacilli, genes that are absent from the avirulent M. microti but present in human pathogen M. tuberculosis or Mycobacterium bovis were searched for. A minimal set of 50 bacterial artificial chromosome (BAC) clones that covers almost all of the genome of M. microti OV254 was constructed, and individual BACs were compared to the corresponding BACs from M. bovis AF2122/97 and M. tuberculosis H37Rv. Comparison of pulsed-field gel-separated DNA digests of BAC clones led to the identification of 10 regions of difference (RD) between M. microti OV254 and M. tuberculosis. A 14-kb chromosomal region (RD1(mic)) that partly overlaps the RD1 deletion in the BCG vaccine strain was missing from the genomes of all nine tested M. microti strains. This region covers 13 genes, Rv3864 to Rv3876, in M. tuberculosis, including those encoding the potent ESAT-6 and CFP-10 antigens. In contrast, RD5(mic), a region that contains three phospholipase C genes (plcA to -C), was missing from only the vole isolates and was present in M. microti strains isolated from humans. Apart from RD1(mic) and RD5(mic) other M. microti-specific deleted regions have been identified (MiD1 to MiD3). Deletion of MiD1 has removed parts of the direct repeat region in M. microti and thus contributes to the characteristic spoligotype of M. microti strains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228284      PMCID: PMC128332          DOI: 10.1128/IAI.70.10.5568-5578.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species.

Authors:  V V Lévy-Frébault; F Portaels
Journal:  Int J Syst Bacteriol       Date:  1992-04

2.  Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains.

Authors:  P W Hermans; D van Soolingen; E M Bik; P E de Haas; J W Dale; J D van Embden
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Protective effects of M. microti vaccine against tuberculosis.

Authors:  L Sula; I Radkovský
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1976

4.  Control and location of acyl-hydrolysing phospholipase activity in pathogenic mycobacteria.

Authors:  P R Wheeler; C Ratledge
Journal:  J Gen Microbiol       Date:  1992-04

5.  Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG.

Authors:  Yukari C Manabe; Cherise P Scott; William R Bishai
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.

Authors:  M A Horwitz; B W Lee; B J Dillon; G Harth
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.

Authors:  P D Hart; I Sutherland
Journal:  Br Med J       Date:  1977-07-30

8.  Phospholipases C are involved in the virulence of Mycobacterium tuberculosis.

Authors:  Catherine Raynaud; Christophe Guilhot; Jean Rauzier; Yann Bordat; Vladimir Pelicic; Riccardo Manganelli; Issar Smith; Brigitte Gicquel; Mary Jackson
Journal:  Mol Microbiol       Date:  2002-07       Impact factor: 3.501

9.  Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers.

Authors:  D van Soolingen; A G van der Zanden; P E de Haas; G T Noordhoek; A Kiers; N A Foudraine; F Portaels; A H Kolk; K Kremer; J D van Embden
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis.

Authors:  Linda M Parsons; Roland Brosch; Stewart T Cole; Akos Somoskövi; Arthur Loder; Gisela Bretzel; Dick Van Soolingen; Yvonne M Hale; Max Salfinger
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more
  47 in total

1.  Revisiting the evolution of Mycobacterium bovis.

Authors:  Serge Mostowy; Jackie Inwald; Steve Gordon; Carlos Martin; Rob Warren; Kristin Kremer; Debby Cousins; Marcel A Behr
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

2.  Mycobacterium microti--pulmonary tuberculosis in an immunocompetent patient.

Authors:  Wolfgang Frank; Emil C Reisinger; Wiltrud Brandt-Hamerla; Ilona Schwede; Werner Handrick
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions.

Authors:  Richard C Huard; Luiz Claudio de Oliveira Lazzarini; W Ray Butler; Dick van Soolingen; John L Ho
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 4.  ESX secretion systems: mycobacterial evolution to counter host immunity.

Authors:  Matthias I Gröschel; Fadel Sayes; Roxane Simeone; Laleh Majlessi; Roland Brosch
Journal:  Nat Rev Microbiol       Date:  2016-09-26       Impact factor: 60.633

5.  High-throughput method for detecting genomic-deletion polymorphisms.

Authors:  Yves-Olivier Luc Goguet de la Salmonière; C C Kim; A G Tsolaki; A S Pym; M S Siegrist; Peter M Small
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis.

Authors:  Jessica L Flint; Joseph C Kowalski; Pavan K Karnati; Keith M Derbyshire
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis.

Authors:  Yukari C Manabe; Arthur M Dannenberg; Sandeep K Tyagi; Christine L Hatem; Mark Yoder; Samuel C Woolwine; Bernard C Zook; M Louise M Pitt; William R Bishai
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex.

Authors:  Serge Mostowy; Debby Cousins; Marcel A Behr
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

9.  Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus.

Authors:  Fabienne Ripoll; Sophie Pasek; Chantal Schenowitz; Carole Dossat; Valérie Barbe; Martin Rottman; Edouard Macheras; Beate Heym; Jean-Louis Herrmann; Mamadou Daffé; Roland Brosch; Jean-Loup Risler; Jean-Louis Gaillard
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

10.  Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene region.

Authors:  Christopher R E McEvoy; Paul D van Helden; Robin M Warren; Nicolaas C Gey van Pittius
Journal:  BMC Evol Biol       Date:  2009-09-21       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.